- LINKS
-
More about this topic
Click here for more information about this topic.
-
- Bookmark this page
- gross
Our Partnering Teams
We are big, but not too big to care
Bayer HealthCare Pharmaceuticals is a strong player in specialty medicine. In the areas we focus on, we have a long-term tradition of belonging to the top players in the field. We do not only offer you in-depth knowledge of therapeutic approaches and specialized development expertise but also excellent sales and marketing capabilities worldwide.
To jointly develop tailor made partnering solutions we have two highly skilled global teams:
Our global innovation sourcing team is your partner for „Early Assets“ and technologies up to clinical Phase I and all interactions with academic partners.
Our global innovation sourcing team is your partner for „Early Assets“ and technologies up to clinical Phase I and all interactions with academic partners.
Our global business development team is responsible for all assets in clinical development and for marketed drugs.
- Age-related macular degeneration (AMD)
- Breast cancer
- Central retinal vein occlusion (CRVO)
- Colorectal Cancer (CRC)
- Contraception
- Diabetes
- Diabetic macular edema (DME)
- Endometriosis
- Erectile dysfunction
- Gastrointestinal stromal tumor (GIST)
- Gynecological therapy
- Heart attack
- Heartattack and stroke
- Hemophilia
- High blood pressure
- Infectious diseases
- Liver cancer
- Lung cancer
- Menopausal complaints
- Multiple sclerosis
- Peripheral arterial occlusive disease
- Premenstrual dysphoric disorder (PMDD)
- Prostate cancer
- Pulmonary arterial hypertension
- Renalcell carcinoma
- Stroke
- Testosterone deficiency
- Thrombosis
- Thyroid Cancer
Page tools
- B/W version
- A | A | A | Font size
